Market open
$
7.13
Change
-0.54 -7.04%
Volume
Volume 7.30m
Oct 4, 2023, 11:55 a.m.
Real time quotes
Previous close
$ 7.67
$ 7.13
Change
-0.54 -7.04%
Day low
Day high
$6.97
$7.78

52 week low
52 week high
$5.61
$25.66

Market cap
$724.08M
Average volume
10.27M
P/E ratio
N/A
Rev. per Employee
$801,884
EPS
-7.27
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on NVAX
-
Novavax Jumps After FDA OKs Updated Covid Shot
- Ben Levisohn
-
Novavax updated COVID vaccine gets FDA approval
- Eleanor Laise
-
Pfizer and Moderna Covid Vaccines Approved by FDA
- Josh Nathan-Kazis
-
New Pfizer and Moderna COVID shots approved by FDA
- Eleanor Laise
-
New Covid Variant Might Not Be That Bad
- Josh Nathan-Kazis
-
COVID is evolving quickly in white-tailed deer, study finds
- Eleanor Laise
-
Covid Hospitalizations Jump. So Could Vaccine Demand.
- Josh Nathan-Kazis
-
Covid Revenues Are Caving. New Boosters May Not Help.
- Josh Nathan-Kazis
-
Novavax upgraded to buy from neutral at B. Riley
- Tomi Kilgore
- Loading more headlines...
Analyst Ratings
Other News on NVAX
-
New Covid-19 Vaccines and More Free Mail-Order Tests. What to Know for This Fall.
- The Wall Street Journal Interactive Edition
-
FDA Authorizes Novavax’s Updated Covid Vaccine
- The Wall Street Journal Interactive Edition
-
A Game Plan for Timing Your Flu, Covid and RSV Shots This Fall
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Biden Waves Through Another Covid Booster
- The Wall Street Journal Interactive Edition
-
A New Omicron Subvariant, Dubbed ‘Eris,’ Heralds Covid-19’s Resurgence
- The Wall Street Journal Interactive Edition
-
A New Omicron Subvariant, Dubbed ‘Eris,’ Heralds Covid-19’s Resurgence
- The Wall Street Journal Interactive Edition
-
Next Covid Shots in the U.S. Will Target Omicron Offshoot XBB.1.5
- The Wall Street Journal Interactive Edition
-
U.S. to Target XBB Strain When Covid Shots Roll Out This Fall
- The Wall Street Journal Interactive Edition
-
Next Covid Boosters to Target New Strain
- The Wall Street Journal Interactive Edition
-
- Edgar Online - (EDG = 10Q, 10K)
-
New Covid-19 Booster Shots: What to Know
- The Wall Street Journal Interactive Edition
-
Single Dose of Omicron-Targeting Vaccines to Become Main Covid-19 Shot in U.S.
- The Wall Street Journal Interactive Edition
-
The Government’s Covid Casualties
- The Wall Street Journal Interactive Edition
-
S&P 500 Ticks Lower After Manufacturing Data
- The Wall Street Journal Interactive Edition
-
- Edgar Online - (EDG = 10Q, 10K)
-
Graham Capital Management, L.P. Buys 1, Sells 4 in 4th Quarter
- GuruFocus.com
-
Novavax to Sell 1.5 Million More Covid Vaccines to U.S.
- The Wall Street Journal Interactive Edition
-
FDA Advisers Back Annual Covid-19 Boosters With Reservations About Rollout
- The Wall Street Journal Interactive Edition
- Loading more headlines...
Press Releases on NVAX
-
Novavax Reports First Quarter 2023 Financial Results and Operational Highlights
- PR Newswire - PRF
-
Novavax to Participate in the BofA Securities 2023 Health Care Conference
- PR Newswire - PRF
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com